Viewing Study NCT03102333



Ignite Creation Date: 2024-05-06 @ 9:54 AM
Last Modification Date: 2024-10-26 @ 12:21 PM
Study NCT ID: NCT03102333
Status: COMPLETED
Last Update Posted: 2018-07-18
First Post: 2017-03-08

Brief Title: Comparison Constant-rate Infusion Plus Demanding Dosing VS Variable-rate Feedback Infusion Plus Demanding Dosing
Sponsor: Chung-Ang University Hosptial Chung-Ang University College of Medicine
Organization: Chung-Ang University Hosptial Chung-Ang University College of Medicine

Study Overview

Official Title: Comparison Constant-rate Infusion Plus Demanding Dosing VS Variable-rate
Status: COMPLETED
Status Verified Date: 2018-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In the case of the newlys developed PCA the infusion rate is increased according to the patients need for bolus button so that the pain can be controlled more efficiently
Detailed Description: In the case of the existing iv-pca the analgesic drug was injected into the patient at a constant rate ex 1 ml hr and additional pain was controlled through the bolus dose 1 ml

As a result the analgesic effect was insufficient or the effect was excessive causing side effects nausea vomiting sedation dizziness Especially In spinal surgery the degree of pain sharply decreases from day 1 to day 2 Classic iv-pca with constant infusion rate can not reflect this result But in the case of the newlys developed PCA the infusion rate is increased according to the patients need for bolus button so that the pain can be controlled more efficiently If the bolus button is not pressed for a certain period of time it is expected that the injection rate will be reduced and the side effect caused by the analgesic agent will be decreased

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None